Skip to content

The Efficacy of transcranial direct current stimulation in treatment of patients with Mild Cognitive Impairment (MCI)

The Efficacy of High Definition anodal transcranial direct current stimulation in treatment of patients with Mild Cognitive Impairment (MCI), A Randomized, double-blind, parallel-controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N163
Enrollment
90
Registered
2021-03-21
Start date
2021-04-09
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive disorder. Mild cognitive disorder

Interventions

Intervention 1: In the first intervention group, anodic TDCS stimulation is performed on the left prefrontal dorsolateral cortex with a current of 2 mA for 20 minutes 5 days a week, for two weeks. Int

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 90 Years

Inclusion criteria

Inclusion criteria: Diagnosis of mild cognitive impairment Education level 4 or more The duration of symptoms of mild cognitive impairment is at least one year

Exclusion criteria

Exclusion criteria: Epilepsy; Taking any medication that affects the central nervous system Focal neurological defects in neurological examination Scalp diseases Previous intracranial surgery, metal inside the head (outside the mouth) such as shrapnel, surgical clips History of recurrent or severe headaches

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Using a quality of life questionnaire.;Cognitive status. Timepoint: Before stimulation, after the second week, one and three months after the end of the study. Method of measurement: Using the Montreal Cognitive Test (MoCA).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Soheila Rezakhani

Kerman University of Medical Sciences

drrezakhani@gmail.com+98 34 3226 4196

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026